Global CGT CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global CGT CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 95

Published Date: 16 Jul 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The CGT CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global CGT CDMO size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global CGT CDMO market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
CGT CDMO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA

Market segment by Application, can be divided into
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others

Market segment by players, this report covers
WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CGT CDMO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CGT CDMO, with revenue, gross margin and global market share of CGT CDMO from 2019 to 2021.
Chapter 3, the CGT CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and CGT CDMO market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe CGT CDMO research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of CGT CDMO
1.2 Classification of CGT CDMO by Type
1.2.1 Overview: Global CGT CDMO Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CGT CDMO Revenue Market Share by Type in 2020
1.2.3 Immune Cells
1.2.4 Stem Cells
1.2.5 Viral Vectors
1.2.6 Plasmid DNA
1.3 Global CGT CDMO Market by Application
1.3.1 Overview: Global CGT CDMO Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Global CGT CDMO Market Size & Forecast
1.5 Global CGT CDMO Market Size and Forecast by Region
1.5.1 Global CGT CDMO Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CGT CDMO Market Size by Region, (2016-2021)
1.5.3 North America CGT CDMO Market Size and Prospect (2016-2026)
1.5.4 Europe CGT CDMO Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CGT CDMO Market Size and Prospect (2016-2026)
1.5.6 South America CGT CDMO Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CGT CDMO Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CGT CDMO Market Drivers
1.6.2 CGT CDMO Market Restraints
1.6.3 CGT CDMO Trends Analysis

2 Company Profiles
2.1 WuXi AppTec
2.1.1 WuXi AppTec Details
2.1.2 WuXi AppTec Major Business
2.1.3 WuXi AppTec CGT CDMO Product and Solutions
2.1.4 WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 WuXi AppTec Recent Developments and Future Plans
2.2 OBiO
2.2.1 OBiO Details
2.2.2 OBiO Major Business
2.2.3 OBiO CGT CDMO Product and Solutions
2.2.4 OBiO CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 OBiO Recent Developments and Future Plans
2.3 GenScript
2.3.1 GenScript Details
2.3.2 GenScript Major Business
2.3.3 GenScript CGT CDMO Product and Solutions
2.3.4 GenScript CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GenScript Recent Developments and Future Plans
2.4 Porton
2.4.1 Porton Details
2.4.2 Porton Major Business
2.4.3 Porton CGT CDMO Product and Solutions
2.4.4 Porton CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Porton Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza CGT CDMO Product and Solutions
2.5.4 Lonza CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Lonza Recent Developments and Future Plans
2.6 Pharmaron
2.6.1 Pharmaron Details
2.6.2 Pharmaron Major Business
2.6.3 Pharmaron CGT CDMO Product and Solutions
2.6.4 Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pharmaron Recent Developments and Future Plans
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent CGT CDMO Product and Solutions
2.7.4 Catalent CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Catalent Recent Developments and Future Plans
2.8 Thermo Fisher
2.8.1 Thermo Fisher Details
2.8.2 Thermo Fisher Major Business
2.8.3 Thermo Fisher CGT CDMO Product and Solutions
2.8.4 Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Thermo Fisher Recent Developments and Future Plans
2.9 Oxford Biomedica (OXB)
2.9.1 Oxford Biomedica (OXB) Details
2.9.2 Oxford Biomedica (OXB) Major Business
2.9.3 Oxford Biomedica (OXB) CGT CDMO Product and Solutions
2.9.4 Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Oxford Biomedica (OXB) Recent Developments and Future Plans
2.10 Asymchem
2.10.1 Asymchem Details
2.10.2 Asymchem Major Business
2.10.3 Asymchem CGT CDMO Product and Solutions
2.10.4 Asymchem CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Asymchem Recent Developments and Future Plans
2.11 Rentschler Biopharma
2.11.1 Rentschler Biopharma Details
2.11.2 Rentschler Biopharma Major Business
2.11.3 Rentschler Biopharma CGT CDMO Product and Solutions
2.11.4 Rentschler Biopharma CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Rentschler Biopharma Recent Developments and Future Plans
2.12 Novartis
2.12.1 Novartis Details
2.12.2 Novartis Major Business
2.12.3 Novartis CGT CDMO Product and Solutions
2.12.4 Novartis CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global CGT CDMO Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 CGT CDMO Players Market Share
3.2.2 Top 10 CGT CDMO Players Market Share
3.2.3 Market Competition Trend
3.3 CGT CDMO Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global CGT CDMO Revenue and Market Share by Type (2016-2021)
4.2 Global CGT CDMO Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global CGT CDMO Revenue Market Share by Application (2016-2021)
5.2 CGT CDMO Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America CGT CDMO Revenue by Type (2016-2026)
6.2 North America CGT CDMO Revenue by Application (2016-2026)
6.3 North America CGT CDMO Market Size by Country
6.3.1 North America CGT CDMO Revenue by Country (2016-2026)
6.3.2 United States CGT CDMO Market Size and Forecast (2016-2026)
6.3.3 Canada CGT CDMO Market Size and Forecast (2016-2026)
6.3.4 Mexico CGT CDMO Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe CGT CDMO Revenue by Type (2016-2026)
7.2 Europe CGT CDMO Revenue by Application (2016-2026)
7.3 Europe CGT CDMO Market Size by Country
7.3.1 Europe CGT CDMO Revenue by Country (2016-2026)
7.3.2 Germany CGT CDMO Market Size and Forecast (2016-2026)
7.3.3 France CGT CDMO Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CGT CDMO Market Size and Forecast (2016-2026)
7.3.5 Russia CGT CDMO Market Size and Forecast (2016-2026)
7.3.6 Italy CGT CDMO Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CGT CDMO Revenue by Type (2016-2026)
8.2 Asia-Pacific CGT CDMO Revenue by Application (2016-2026)
8.3 Asia-Pacific CGT CDMO Market Size by Region
8.3.1 Asia-Pacific CGT CDMO Revenue by Region (2016-2026)
8.3.2 China CGT CDMO Market Size and Forecast (2016-2026)
8.3.3 Japan CGT CDMO Market Size and Forecast (2016-2026)
8.3.4 South Korea CGT CDMO Market Size and Forecast (2016-2026)
8.3.5 India CGT CDMO Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CGT CDMO Market Size and Forecast (2016-2026)
8.3.7 Australia CGT CDMO Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America CGT CDMO Revenue by Type (2016-2026)
9.2 South America CGT CDMO Revenue by Application (2016-2026)
9.3 South America CGT CDMO Market Size by Country
9.3.1 South America CGT CDMO Revenue by Country (2016-2026)
9.3.2 Brazil CGT CDMO Market Size and Forecast (2016-2026)
9.3.3 Argentina CGT CDMO Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CGT CDMO Revenue by Type (2016-2026)
10.2 Middle East & Africa CGT CDMO Revenue by Application (2016-2026)
10.3 Middle East & Africa CGT CDMO Market Size by Country
10.3.1 Middle East & Africa CGT CDMO Revenue by Country (2016-2026)
10.3.2 Turkey CGT CDMO Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CGT CDMO Market Size and Forecast (2016-2026)
10.3.4 UAE CGT CDMO Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global CGT CDMO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CGT CDMO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CGT CDMO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CGT CDMO Revenue (USD Million) by Region (2016-2021)
Table 5. Global CGT CDMO Revenue Market Share by Region (2021-2026)
Table 6. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 7. WuXi AppTec Major Business
Table 8. WuXi AppTec CGT CDMO Product and Solutions
Table 9. WuXi AppTec CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. OBiO Corporate Information, Head Office, and Major Competitors
Table 11. OBiO Major Business
Table 12. OBiO CGT CDMO Product and Solutions
Table 13. OBiO CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GenScript Corporate Information, Head Office, and Major Competitors
Table 15. GenScript Major Business
Table 16. GenScript CGT CDMO Product and Solutions
Table 17. GenScript CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Porton Corporate Information, Head Office, and Major Competitors
Table 19. Porton Major Business
Table 20. Porton CGT CDMO Product and Solutions
Table 21. Porton CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Lonza Corporate Information, Head Office, and Major Competitors
Table 23. Lonza Major Business
Table 24. Lonza CGT CDMO Product and Solutions
Table 25. Lonza CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pharmaron Corporate Information, Head Office, and Major Competitors
Table 27. Pharmaron Major Business
Table 28. Pharmaron CGT CDMO Product and Solutions
Table 29. Pharmaron CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Catalent Corporate Information, Head Office, and Major Competitors
Table 31. Catalent Major Business
Table 32. Catalent CGT CDMO Product and Solutions
Table 33. Catalent CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Major Business
Table 36. Thermo Fisher CGT CDMO Product and Solutions
Table 37. Thermo Fisher CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Oxford Biomedica (OXB) Corporate Information, Head Office, and Major Competitors
Table 39. Oxford Biomedica (OXB) Major Business
Table 40. Oxford Biomedica (OXB) CGT CDMO Product and Solutions
Table 41. Oxford Biomedica (OXB) CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Asymchem Corporate Information, Head Office, and Major Competitors
Table 43. Asymchem Major Business
Table 44. Asymchem CGT CDMO Product and Solutions
Table 45. Asymchem CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Rentschler Biopharma Corporate Information, Head Office, and Major Competitors
Table 47. Rentschler Biopharma Major Business
Table 48. Rentschler Biopharma CGT CDMO Product and Solutions
Table 49. Rentschler Biopharma CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Novartis Corporate Information, Head Office, and Major Competitors
Table 51. Novartis Major Business
Table 52. Novartis CGT CDMO Product and Solutions
Table 53. Novartis CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global CGT CDMO Revenue (USD Million) by Players (2019-2021)
Table 55. Global CGT CDMO Revenue Share by Players (2019-2021)
Table 56. Breakdown of CGT CDMO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. CGT CDMO Players Head Office, Products and Services Provided
Table 58. CGT CDMO Mergers & Acquisitions in the Past Five Years
Table 59. CGT CDMO New Entrants and Expansion Plans
Table 60. Global CGT CDMO Revenue (USD Million) by Type (2016-2021)
Table 61. Global CGT CDMO Revenue Share by Type (2016-2021)
Table 62. Global CGT CDMO Revenue Forecast by Type (2021-2026)
Table 63. Global CGT CDMO Revenue by Application (2016-2021)
Table 64. Global CGT CDMO Revenue Forecast by Application (2021-2026)
Table 65. North America CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 66. North America CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 67. North America CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 68. North America CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 69. North America CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 70. North America CGT CDMO Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe CGT CDMO Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific CGT CDMO Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific CGT CDMO Revenue by Region (2021-2026) & (USD Million)
Table 83. South America CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 84. South America CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 85. South America CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 86. South America CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 87. South America CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 88. South America CGT CDMO Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa CGT CDMO Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CGT CDMO Picture
Figure 2. Global CGT CDMO Revenue Market Share by Type in 2020
Figure 3. Immune Cells
Figure 4. Stem Cells
Figure 5. Viral Vectors
Figure 6. Plasmid DNA
Figure 7. CGT CDMO Revenue Market Share by Application in 2020
Figure 8. Pharmaceutical and Biotechnology Companies Picture
Figure 9. Research and Academic Institutions Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global CGT CDMO Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global CGT CDMO Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global CGT CDMO Revenue Market Share by Region (2016-2026)
Figure 15. Global CGT CDMO Revenue Market Share by Region in 2020
Figure 16. North America CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. CGT CDMO Market Drivers
Figure 22. CGT CDMO Market Restraints
Figure 23. CGT CDMO Market Trends
Figure 24. WuXi AppTec Recent Developments and Future Plans
Figure 25. OBiO Recent Developments and Future Plans
Figure 26. GenScript Recent Developments and Future Plans
Figure 27. Porton Recent Developments and Future Plans
Figure 28. Lonza Recent Developments and Future Plans
Figure 29. Pharmaron Recent Developments and Future Plans
Figure 30. Catalent Recent Developments and Future Plans
Figure 31. Thermo Fisher Recent Developments and Future Plans
Figure 32. Oxford Biomedica (OXB) Recent Developments and Future Plans
Figure 33. Asymchem Recent Developments and Future Plans
Figure 34. Rentschler Biopharma Recent Developments and Future Plans
Figure 35. Novartis Recent Developments and Future Plans
Figure 36. Global CGT CDMO Revenue Share by Players in 2020
Figure 37. CGT CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players CGT CDMO Revenue Market Share in 2020
Figure 39. Global Top 10 Players CGT CDMO Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global CGT CDMO Revenue Share by Type in 2020
Figure 42. Global CGT CDMO Market Share Forecast by Type (2021-2026)
Figure 43. Global CGT CDMO Revenue Share by Application in 2020
Figure 44. Global CGT CDMO Market Share Forecast by Application (2021-2026)
Figure 45. North America CGT CDMO Sales Market Share by Type (2016-2026)
Figure 46. North America CGT CDMO Sales Market Share by Application (2016-2026)
Figure 47. North America CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 48. United States CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe CGT CDMO Sales Market Share by Type (2016-2026)
Figure 52. Europe CGT CDMO Sales Market Share by Application (2016-2026)
Figure 53. Europe CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 54. Germany CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific CGT CDMO Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific CGT CDMO Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific CGT CDMO Revenue Market Share by Region (2016-2026)
Figure 62. China CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America CGT CDMO Sales Market Share by Type (2016-2026)
Figure 69. South America CGT CDMO Sales Market Share by Application (2016-2026)
Figure 70. South America CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 71. Brazil CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa CGT CDMO Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa CGT CDMO Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 76. Turkey CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global CGT CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global CGT CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 95

Published Date: 16 Jul 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The CGT CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global CGT CDMO size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global CGT CDMO market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
CGT CDMO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA

Market segment by Application, can be divided into
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others

Market segment by players, this report covers
WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CGT CDMO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CGT CDMO, with revenue, gross margin and global market share of CGT CDMO from 2019 to 2021.
Chapter 3, the CGT CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and CGT CDMO market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe CGT CDMO research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of CGT CDMO
1.2 Classification of CGT CDMO by Type
1.2.1 Overview: Global CGT CDMO Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CGT CDMO Revenue Market Share by Type in 2020
1.2.3 Immune Cells
1.2.4 Stem Cells
1.2.5 Viral Vectors
1.2.6 Plasmid DNA
1.3 Global CGT CDMO Market by Application
1.3.1 Overview: Global CGT CDMO Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Global CGT CDMO Market Size & Forecast
1.5 Global CGT CDMO Market Size and Forecast by Region
1.5.1 Global CGT CDMO Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CGT CDMO Market Size by Region, (2016-2021)
1.5.3 North America CGT CDMO Market Size and Prospect (2016-2026)
1.5.4 Europe CGT CDMO Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CGT CDMO Market Size and Prospect (2016-2026)
1.5.6 South America CGT CDMO Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CGT CDMO Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CGT CDMO Market Drivers
1.6.2 CGT CDMO Market Restraints
1.6.3 CGT CDMO Trends Analysis

2 Company Profiles
2.1 WuXi AppTec
2.1.1 WuXi AppTec Details
2.1.2 WuXi AppTec Major Business
2.1.3 WuXi AppTec CGT CDMO Product and Solutions
2.1.4 WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 WuXi AppTec Recent Developments and Future Plans
2.2 OBiO
2.2.1 OBiO Details
2.2.2 OBiO Major Business
2.2.3 OBiO CGT CDMO Product and Solutions
2.2.4 OBiO CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 OBiO Recent Developments and Future Plans
2.3 GenScript
2.3.1 GenScript Details
2.3.2 GenScript Major Business
2.3.3 GenScript CGT CDMO Product and Solutions
2.3.4 GenScript CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GenScript Recent Developments and Future Plans
2.4 Porton
2.4.1 Porton Details
2.4.2 Porton Major Business
2.4.3 Porton CGT CDMO Product and Solutions
2.4.4 Porton CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Porton Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza CGT CDMO Product and Solutions
2.5.4 Lonza CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Lonza Recent Developments and Future Plans
2.6 Pharmaron
2.6.1 Pharmaron Details
2.6.2 Pharmaron Major Business
2.6.3 Pharmaron CGT CDMO Product and Solutions
2.6.4 Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pharmaron Recent Developments and Future Plans
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent CGT CDMO Product and Solutions
2.7.4 Catalent CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Catalent Recent Developments and Future Plans
2.8 Thermo Fisher
2.8.1 Thermo Fisher Details
2.8.2 Thermo Fisher Major Business
2.8.3 Thermo Fisher CGT CDMO Product and Solutions
2.8.4 Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Thermo Fisher Recent Developments and Future Plans
2.9 Oxford Biomedica (OXB)
2.9.1 Oxford Biomedica (OXB) Details
2.9.2 Oxford Biomedica (OXB) Major Business
2.9.3 Oxford Biomedica (OXB) CGT CDMO Product and Solutions
2.9.4 Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Oxford Biomedica (OXB) Recent Developments and Future Plans
2.10 Asymchem
2.10.1 Asymchem Details
2.10.2 Asymchem Major Business
2.10.3 Asymchem CGT CDMO Product and Solutions
2.10.4 Asymchem CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Asymchem Recent Developments and Future Plans
2.11 Rentschler Biopharma
2.11.1 Rentschler Biopharma Details
2.11.2 Rentschler Biopharma Major Business
2.11.3 Rentschler Biopharma CGT CDMO Product and Solutions
2.11.4 Rentschler Biopharma CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Rentschler Biopharma Recent Developments and Future Plans
2.12 Novartis
2.12.1 Novartis Details
2.12.2 Novartis Major Business
2.12.3 Novartis CGT CDMO Product and Solutions
2.12.4 Novartis CGT CDMO Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global CGT CDMO Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 CGT CDMO Players Market Share
3.2.2 Top 10 CGT CDMO Players Market Share
3.2.3 Market Competition Trend
3.3 CGT CDMO Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global CGT CDMO Revenue and Market Share by Type (2016-2021)
4.2 Global CGT CDMO Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global CGT CDMO Revenue Market Share by Application (2016-2021)
5.2 CGT CDMO Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America CGT CDMO Revenue by Type (2016-2026)
6.2 North America CGT CDMO Revenue by Application (2016-2026)
6.3 North America CGT CDMO Market Size by Country
6.3.1 North America CGT CDMO Revenue by Country (2016-2026)
6.3.2 United States CGT CDMO Market Size and Forecast (2016-2026)
6.3.3 Canada CGT CDMO Market Size and Forecast (2016-2026)
6.3.4 Mexico CGT CDMO Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe CGT CDMO Revenue by Type (2016-2026)
7.2 Europe CGT CDMO Revenue by Application (2016-2026)
7.3 Europe CGT CDMO Market Size by Country
7.3.1 Europe CGT CDMO Revenue by Country (2016-2026)
7.3.2 Germany CGT CDMO Market Size and Forecast (2016-2026)
7.3.3 France CGT CDMO Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CGT CDMO Market Size and Forecast (2016-2026)
7.3.5 Russia CGT CDMO Market Size and Forecast (2016-2026)
7.3.6 Italy CGT CDMO Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CGT CDMO Revenue by Type (2016-2026)
8.2 Asia-Pacific CGT CDMO Revenue by Application (2016-2026)
8.3 Asia-Pacific CGT CDMO Market Size by Region
8.3.1 Asia-Pacific CGT CDMO Revenue by Region (2016-2026)
8.3.2 China CGT CDMO Market Size and Forecast (2016-2026)
8.3.3 Japan CGT CDMO Market Size and Forecast (2016-2026)
8.3.4 South Korea CGT CDMO Market Size and Forecast (2016-2026)
8.3.5 India CGT CDMO Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CGT CDMO Market Size and Forecast (2016-2026)
8.3.7 Australia CGT CDMO Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America CGT CDMO Revenue by Type (2016-2026)
9.2 South America CGT CDMO Revenue by Application (2016-2026)
9.3 South America CGT CDMO Market Size by Country
9.3.1 South America CGT CDMO Revenue by Country (2016-2026)
9.3.2 Brazil CGT CDMO Market Size and Forecast (2016-2026)
9.3.3 Argentina CGT CDMO Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CGT CDMO Revenue by Type (2016-2026)
10.2 Middle East & Africa CGT CDMO Revenue by Application (2016-2026)
10.3 Middle East & Africa CGT CDMO Market Size by Country
10.3.1 Middle East & Africa CGT CDMO Revenue by Country (2016-2026)
10.3.2 Turkey CGT CDMO Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CGT CDMO Market Size and Forecast (2016-2026)
10.3.4 UAE CGT CDMO Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global CGT CDMO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CGT CDMO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CGT CDMO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CGT CDMO Revenue (USD Million) by Region (2016-2021)
Table 5. Global CGT CDMO Revenue Market Share by Region (2021-2026)
Table 6. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 7. WuXi AppTec Major Business
Table 8. WuXi AppTec CGT CDMO Product and Solutions
Table 9. WuXi AppTec CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. OBiO Corporate Information, Head Office, and Major Competitors
Table 11. OBiO Major Business
Table 12. OBiO CGT CDMO Product and Solutions
Table 13. OBiO CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GenScript Corporate Information, Head Office, and Major Competitors
Table 15. GenScript Major Business
Table 16. GenScript CGT CDMO Product and Solutions
Table 17. GenScript CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Porton Corporate Information, Head Office, and Major Competitors
Table 19. Porton Major Business
Table 20. Porton CGT CDMO Product and Solutions
Table 21. Porton CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Lonza Corporate Information, Head Office, and Major Competitors
Table 23. Lonza Major Business
Table 24. Lonza CGT CDMO Product and Solutions
Table 25. Lonza CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pharmaron Corporate Information, Head Office, and Major Competitors
Table 27. Pharmaron Major Business
Table 28. Pharmaron CGT CDMO Product and Solutions
Table 29. Pharmaron CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Catalent Corporate Information, Head Office, and Major Competitors
Table 31. Catalent Major Business
Table 32. Catalent CGT CDMO Product and Solutions
Table 33. Catalent CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Major Business
Table 36. Thermo Fisher CGT CDMO Product and Solutions
Table 37. Thermo Fisher CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Oxford Biomedica (OXB) Corporate Information, Head Office, and Major Competitors
Table 39. Oxford Biomedica (OXB) Major Business
Table 40. Oxford Biomedica (OXB) CGT CDMO Product and Solutions
Table 41. Oxford Biomedica (OXB) CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Asymchem Corporate Information, Head Office, and Major Competitors
Table 43. Asymchem Major Business
Table 44. Asymchem CGT CDMO Product and Solutions
Table 45. Asymchem CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Rentschler Biopharma Corporate Information, Head Office, and Major Competitors
Table 47. Rentschler Biopharma Major Business
Table 48. Rentschler Biopharma CGT CDMO Product and Solutions
Table 49. Rentschler Biopharma CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Novartis Corporate Information, Head Office, and Major Competitors
Table 51. Novartis Major Business
Table 52. Novartis CGT CDMO Product and Solutions
Table 53. Novartis CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global CGT CDMO Revenue (USD Million) by Players (2019-2021)
Table 55. Global CGT CDMO Revenue Share by Players (2019-2021)
Table 56. Breakdown of CGT CDMO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. CGT CDMO Players Head Office, Products and Services Provided
Table 58. CGT CDMO Mergers & Acquisitions in the Past Five Years
Table 59. CGT CDMO New Entrants and Expansion Plans
Table 60. Global CGT CDMO Revenue (USD Million) by Type (2016-2021)
Table 61. Global CGT CDMO Revenue Share by Type (2016-2021)
Table 62. Global CGT CDMO Revenue Forecast by Type (2021-2026)
Table 63. Global CGT CDMO Revenue by Application (2016-2021)
Table 64. Global CGT CDMO Revenue Forecast by Application (2021-2026)
Table 65. North America CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 66. North America CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 67. North America CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 68. North America CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 69. North America CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 70. North America CGT CDMO Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe CGT CDMO Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific CGT CDMO Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific CGT CDMO Revenue by Region (2021-2026) & (USD Million)
Table 83. South America CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 84. South America CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 85. South America CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 86. South America CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 87. South America CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 88. South America CGT CDMO Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa CGT CDMO Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa CGT CDMO Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa CGT CDMO Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa CGT CDMO Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa CGT CDMO Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa CGT CDMO Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CGT CDMO Picture
Figure 2. Global CGT CDMO Revenue Market Share by Type in 2020
Figure 3. Immune Cells
Figure 4. Stem Cells
Figure 5. Viral Vectors
Figure 6. Plasmid DNA
Figure 7. CGT CDMO Revenue Market Share by Application in 2020
Figure 8. Pharmaceutical and Biotechnology Companies Picture
Figure 9. Research and Academic Institutions Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global CGT CDMO Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global CGT CDMO Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global CGT CDMO Revenue Market Share by Region (2016-2026)
Figure 15. Global CGT CDMO Revenue Market Share by Region in 2020
Figure 16. North America CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa CGT CDMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. CGT CDMO Market Drivers
Figure 22. CGT CDMO Market Restraints
Figure 23. CGT CDMO Market Trends
Figure 24. WuXi AppTec Recent Developments and Future Plans
Figure 25. OBiO Recent Developments and Future Plans
Figure 26. GenScript Recent Developments and Future Plans
Figure 27. Porton Recent Developments and Future Plans
Figure 28. Lonza Recent Developments and Future Plans
Figure 29. Pharmaron Recent Developments and Future Plans
Figure 30. Catalent Recent Developments and Future Plans
Figure 31. Thermo Fisher Recent Developments and Future Plans
Figure 32. Oxford Biomedica (OXB) Recent Developments and Future Plans
Figure 33. Asymchem Recent Developments and Future Plans
Figure 34. Rentschler Biopharma Recent Developments and Future Plans
Figure 35. Novartis Recent Developments and Future Plans
Figure 36. Global CGT CDMO Revenue Share by Players in 2020
Figure 37. CGT CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players CGT CDMO Revenue Market Share in 2020
Figure 39. Global Top 10 Players CGT CDMO Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global CGT CDMO Revenue Share by Type in 2020
Figure 42. Global CGT CDMO Market Share Forecast by Type (2021-2026)
Figure 43. Global CGT CDMO Revenue Share by Application in 2020
Figure 44. Global CGT CDMO Market Share Forecast by Application (2021-2026)
Figure 45. North America CGT CDMO Sales Market Share by Type (2016-2026)
Figure 46. North America CGT CDMO Sales Market Share by Application (2016-2026)
Figure 47. North America CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 48. United States CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe CGT CDMO Sales Market Share by Type (2016-2026)
Figure 52. Europe CGT CDMO Sales Market Share by Application (2016-2026)
Figure 53. Europe CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 54. Germany CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific CGT CDMO Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific CGT CDMO Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific CGT CDMO Revenue Market Share by Region (2016-2026)
Figure 62. China CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America CGT CDMO Sales Market Share by Type (2016-2026)
Figure 69. South America CGT CDMO Sales Market Share by Application (2016-2026)
Figure 70. South America CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 71. Brazil CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa CGT CDMO Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa CGT CDMO Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa CGT CDMO Revenue Market Share by Country (2016-2026)
Figure 76. Turkey CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE CGT CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now